Assenagon Asset Management S.A. Adicet Bio, Inc. Transaction History

Assenagon Asset Management S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$7.72 - $21.27 $2.97 Million - $8.19 Million	-384,903 Reduced 92.11%	32,960 $295,000
Q3 2022 Oct 27, 2022	SELL	$13.43 - $18.74 $6.14 Million - $8.56 Million	-456,877 Reduced 52.23%	417,863 $5.94 Million
Q2 2022 Jul 27, 2022	BUY	$10.26 - $20.81 $8.97 Million - $18.2 Million	874,740 New	874,740 $12.8 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.